1Weissman IL,Anderson D J, Gage F. Stem and progenitor cells: ori- gins, phenotypes, hneage commitments, and transdifferentiations [J]. Annu Rev Cell Dev Biol,2001,17 :387 -403.
2Muguruma Y, Yahata T, Miyatake H, et al. Reconstitution of the functional human hematopoietic microenvironment derived from hu- man mesenchymal stem cells in the routine bone marrow compart- ment [J]. Blood,2006,107(5) :1878 - 1887.
3Wang Y,Probin V, Zhou D. Cancer therapy-induced residual bone marrow injury-Mechanisms of induction and implication for therapy [J]. Curr Cancer Ther Rev,2006,2(3) :271 -279.
4Wickremasinghe RG, Hoffbrand AV. Biochemical and genetic con- trol of apoptosis : relevance to nominal hematopoiesis and hematolog- ical malignancies. [J]. Blood, 1999,93 ( 11 ) :3587 - 300.
5Hellman S, Botnick LE. Stem cell depletion: an explanation of the late effects of cytotoxins[ J]. Int J Radiat Oncol Biol Phys, 1977,2 (1-2):181-184.
6Toussaint O, Medrano EE, von Zglinicki T. Cellular and molecular mechanisms of stress-induced premature senescence (SIPS) of hu- man diploid fibroblasts and melanocytes [ J ]. Exp Gerontol, 2000, 35(8) :927 -945.
7Saloustros E, Tryfonidis K, Georgoulias V. Prophylactic and thera- peutic strategies in chemotherapy-induced neutropenia [ J]. Expert Opin Pharmacother, 2011,12 ( 6 ) : 851 - 863.
8Noisakran S,Onlamoon N, Hsiao HM, et al. Infection of bone mar- row cells by dengue virus in vivo [ J ]. Exp Hematol,2012,40(3 ) : 250 - 259. e4.
